Experiments
Searchable full-text extractions: founding hypothesis, core claims, experimental setups, key results and statistics — pulled out of each paper as structure. Search a cell line, an assay or an entity (e.g. HUH7) and find every paper that worked with it. This corpus stands on its own: most entries carry no reproduction assessment (yet).
-
Full-text index only
CTCFBSDB: a CTCF-binding site database for characterization of vertebrate genomic insulators.
PMID 17981843 · PMC2238977 · Nucleic acids research · 2008 · 7 claims · 8 setups
CTCF is the only identified trans-acting factor in vertebrates that confers enhancer-blocking insulator activity
-
Full-text index only
EpiXFormer: a cross-attention neural network for predicting cell type-specific transcription factor binding sites.
PMID 41527854 · PMC12796812 · Briefings in bioinformatics · 2026 · 8 claims · 8 setups
EpiXFormer achieves high accuracy (mean AUROC ~0.99) predicting binding sites of both TFs and non-sequence-specific DBPs across 199 DBP-cell type pairs
-
Full-text index only
High-throughput chromatin information enables accurate tissue-specific prediction of transcription factor binding sites.
PMID 18988630 · PMC2662491 · Nucleic acids research · 2009 · 8 claims · 8 setups
Incorporating H3K4me3 chromatin modification estimates greatly improves the accuracy of in silico prediction of in vivo TF binding for a wide range of TFs in human and mouse
-
Full-text index only
CLAMP: predicting specific protein-mediated chromatin loops in diverse species with a chromatin accessibility language model.
PMID 41555433 · PMC12903630 · Genome biology · 2026 · 8 claims · 8 setups
CLAMP, a chromatin-accessibility language model, predicts protein-mediated chromatin loops across 10 species, 18 proteins, and 24 cell types with superior performance versus existing methods.
-
Full-text index only
Distinguishing benign from pathogenic duplications involving GPR101 and VGLL1-adjacent enhancers in the clinical setting with the bioinformatic tool POSTRE.
PMID 41540017 · PMC12890961 · NPJ genomic medicine · 2026 · 6 claims · 7 setups
POSTRE correctly classified all 34 GPR101-associated duplications (27 pathogenic X-LAG, 7 non-pathogenic) as pathogenic or benign